Our previous work indicated that a subanesthetic dose of ketamine could alleviate PTSD-like effects in the rat model induced by SPS&S by inhibiting the expression of HCN1 and up-regulating the BDNF protein levels in the PFC3. The gene discussed is BDNF; the disease is post-traumatic stress disorder.